245 related articles for article (PubMed ID: 22002331)
41. Decision making in primary sacral tumors.
Puri A; Agarwal MG; Shah M; Srinivas CH; Shukla PJ; Shrikhande SV; Jambhekar NA
Spine J; 2009 May; 9(5):396-403. PubMed ID: 19059810
[TBL] [Abstract][Full Text] [Related]
42. Chordoma cutis.
Rubin AI; Bagel J; Niedt G
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S105-8. PubMed ID: 15858504
[TBL] [Abstract][Full Text] [Related]
43. [Metastatic chordoma. General review apropos of 2 cases].
Raguin JM; Wendling D; Montcuquet P; Guidet M
Rev Rhum Mal Osteoartic; 1987; 54(7-9):575-82. PubMed ID: 3313668
[TBL] [Abstract][Full Text] [Related]
44. Pulmonary tumor with notochordal differentiation: report of 2 cases suggestive of benign notochordal cell tumor of extraosseous origin.
Kikuchi Y; Yamaguchi T; Kishi H; Azuhata K; Kimizuka G; Hiroshima K; Nakatani Y
Am J Surg Pathol; 2011 Aug; 35(8):1158-64. PubMed ID: 21716081
[TBL] [Abstract][Full Text] [Related]
45. Dedifferentiated chordoma arising in irradiated sacral chordoma.
Ikeda H; Honjo J; Sakurai H; Mitsuhashi N; Fukuda T; Niibe H
Radiat Med; 1997; 15(2):109-11. PubMed ID: 9192436
[TBL] [Abstract][Full Text] [Related]
46. [Clinico-diagnostic aspects and therapeutic considerations of the combined surgical and radiotherapeutic approach in 2 cases of sacrococcygeal chordoma: our experience].
Zoppi S; Maritato F; Pavero R; Costanzo A; Cariati A; Maritato P; Serafino G; Casano A; Biggi S; Prandi M; Terrizzi A; Valleriani M; Fornaro R
G Chir; 1997 Mar; 18(3):107-10. PubMed ID: 9206489
[TBL] [Abstract][Full Text] [Related]
47. Value of immunocytochemistry in aspiration cytology of sacrococcygeal chordoma. A report of two cases.
Plate KH; Bittinger A
Acta Cytol; 1992; 36(1):87-90. PubMed ID: 1546518
[TBL] [Abstract][Full Text] [Related]
48. Poorly differentiated chordoma with whole-genome doubling evolving from a SMARCB1-deficient conventional chordoma: A case report.
Curcio C; Cimera R; Aryeequaye R; Rao M; Fabbri N; Zhang Y; Hameed M
Genes Chromosomes Cancer; 2021 Jan; 60(1):43-48. PubMed ID: 32920865
[TBL] [Abstract][Full Text] [Related]
49. Establishment and genomic characterization of the new chordoma cell line Chor-IN-1.
Bosotti R; Magnaghi P; Di Bella S; Cozzi L; Cusi C; Bozzi F; Beltrami N; Carapezza G; Ballinari D; Amboldi N; Lupi R; Somaschini A; Raddrizzani L; Salom B; Galvani A; Stacchiotti S; Tamborini E; Isacchi A
Sci Rep; 2017 Aug; 7(1):9226. PubMed ID: 28835717
[TBL] [Abstract][Full Text] [Related]
50. [Sacrococcygeal chordoma. Considerations on a single clinical case].
Lombari C; Matarazzo L; Izzolino GM
Chir Organi Mov; 1981; 67(2):239-45. PubMed ID: 7172830
[No Abstract] [Full Text] [Related]
51. [Sacrococcygeal chordoma. A case report].
Marinelli A; Tambato F; Stazi F; Stazi C
Clin Ter; 1990 Oct; 135(1):47-50. PubMed ID: 2149542
[TBL] [Abstract][Full Text] [Related]
52. Fine-needle aspiration cytology of sacrococcygeal chordoma.
Nijhawan VS; Rajwanshi A; Das A; Jayaram N; Gupta SK
Diagn Cytopathol; 1989; 5(4):404-7. PubMed ID: 2612318
[TBL] [Abstract][Full Text] [Related]
53. Chordomas with malignant spindle cell components. A DNA flow cytometric and immunohistochemical study with histogenetic implications.
Hruban RH; Traganos F; Reuter VE; Huvos AG
Am J Pathol; 1990 Aug; 137(2):435-47. PubMed ID: 1696786
[TBL] [Abstract][Full Text] [Related]
54. New candidate chromosomal regions for chordoma development.
Bayrakli F; Guney I; Kilic T; Ozek M; Pamir MN
Surg Neurol; 2007 Oct; 68(4):425-30; discussion 430. PubMed ID: 17714767
[TBL] [Abstract][Full Text] [Related]
55. Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategies.
Gellner V; Tomazic PV; Lohberger B; Meditz K; Heitzer E; Mokry M; Koele W; Leithner A; Liegl-Atzwanger B; Rinner B
Sci Rep; 2016 Apr; 6():24195. PubMed ID: 27072875
[TBL] [Abstract][Full Text] [Related]
56. The potential function of microRNA in chordomas.
Gulluoglu S; Tuysuz EC; Kuskucu A; Ture U; Atalay B; Sahin F; Bayrak OF
Gene; 2016 Jul; 585(1):76-83. PubMed ID: 27016303
[TBL] [Abstract][Full Text] [Related]
57. Cytogenetics of sacral chordoma.
DeBoer JM; Neff JR; Bridge JA
Cancer Genet Cytogenet; 1992 Nov; 64(1):95-6. PubMed ID: 1458457
[TBL] [Abstract][Full Text] [Related]
58. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas.
Vujovic S; Henderson S; Presneau N; Odell E; Jacques TS; Tirabosco R; Boshoff C; Flanagan AM
J Pathol; 2006 Jun; 209(2):157-65. PubMed ID: 16538613
[TBL] [Abstract][Full Text] [Related]
59. Cytologic, cytochemical, immunocytochemical and ultrastructural diagnosis of a sacrococcygeal chordoma in a fine needle aspiration biopsy specimen.
Plaza JA; Ballestín C; Pérez-Barrios A; Martínez MA; de Agustín P
Acta Cytol; 1989; 33(1):89-92. PubMed ID: 2644745
[TBL] [Abstract][Full Text] [Related]
60. The role of extracellular factors in human metastatic chordoma cell growth in vitro.
Ostroumov E; Hunter CJ
Spine (Phila Pa 1976); 2007 Dec; 32(26):2957-64. PubMed ID: 18091487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
